| Wed, Sep 23, 2009 | | • | Novo Nordisk: FDA diabetes-drug comment deferred
at MarketWatch (Wed, Sep 23)
| | Wed, Sep 9, 2009 | | • | 3 Stocks Hitting High Notes
at Motley Fool (Wed, Sep 9)
| | Thu, Aug 27, 2009 | | • | 7 Shots at Superior Returns
at Motley Fool (Thu, Aug 27)
| | Mon, Aug 24, 2009 | | • | ETF Exposes Forgotten Part of Europe
at TheStreet.com (Mon, Aug 24)
| | Thu, Aug 20, 2009 | | • | [$$] Nordic ETF Could Get a Cold Reception
at RealMoney by TheStreet.com (Thu, Aug 20)
| | Wed, Aug 19, 2009 | | • | The Boring Old Trick That Makes You Money
at Motley Fool (Wed, Aug 19)
| | Fri, Aug 7, 2009 | | • | Novo Nordisk cut at Goldman, little upside
at MarketWatch (Fri, Aug 7)
| | Thu, Aug 6, 2009 | | • | Novo Nordisk profit rises 21%; beats forecasts
at MarketWatch (Thu, Aug 6)
| | Mon, Jul 27, 2009 | | • | Liraglutide Lowered Blood Sugar and Weight in African Americans With Type 2 Diabetes, Phase 3 Data Showed
Marketwire (Mon, Jul 27)
| | Sat, Jul 25, 2009 | | • | Liraglutide Lowered Blood Sugar and Weight in African Americans With Type 2 Diabetes, Phase 3 Data Showed
Marketwire (Sat, Jul 25)
| | Wed, Jul 22, 2009 | | • | The Blockbuster Around the Corner
at Motley Fool (Wed, Jul 22)
| | Thu, Jul 16, 2009 | | • | Dismissing An Insulin-Cancer Link
at Forbes.com (Thu, Jul 16)
| | Wed, Jul 15, 2009 | | • | The Magic of the Earnings Yield
at Motley Fool (Wed, Jul 15)
| | • | Sanofi: Panel says Lantus study inconclusive
at MarketWatch (Wed, Jul 15)
| | Wed, Jul 8, 2009 | | • | The Best Reason to Save
at Motley Fool (Wed, Jul 8)
| | Wed, Jul 1, 2009 | | • | Your First Move For Thursday July 2nd
at CNBC (Wed, Jul 1)
| | • | [video] Stock of the Day: NVO
at CNBC (Wed, Jul 1)
| | • | Novo Nordisk A/S -- Treasury Stock
Marketwire (Wed, Jul 1)
| | Mon, Jun 29, 2009 | | • | Lantus Results: Reply Hazy, Try Again Later
at Motley Fool (Mon, Jun 29)
| | Fri, Jun 19, 2009 | | • | MannKind Needs More Leaps
at Motley Fool (Fri, Jun 19)
| | Thu, Jun 18, 2009 | | • | Your Stocks Just Got Riskier
at Motley Fool (Thu, Jun 18)
| | Mon, Jun 8, 2009 | | • | The Lancet Publishes Direct Comparison Study Between Liraglutide and Exenatide
Marketwire (Mon, Jun 8)
| | • | For the RECORD ...
at Motley Fool (Mon, Jun 8)
| | • | [video] Investing in Diabetes
at CNBC (Mon, Jun 8)
| | • | Two-Year Data Show Investigational Drug Liraglutide More Effective at Lowering Blood Sugar Than Glimepiride
Marketwire (Mon, Jun 8)
|
Add NVO News to My Yahoo!:
 
| |
|
0.08% Nasdaq 
0.35%
Headlines
